Technical Analysis for ICU - SeaStar Medical Holding Corporation
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 3.03 | -2.26% | -0.07 |
ICU closed down 2.26 percent on Friday, November 1, 2024, on 3.18 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Nov 12
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing Low | Bearish | 0.00% | |
Volume Surge | Other | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
New 52 Week Low | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Down 5 Days in a Row | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% |
Alert | Time |
---|---|
Possible NR7 | about 18 hours ago |
Rose Above Lower Bollinger Band | about 21 hours ago |
2x Volume Pace | about 21 hours ago |
1.5x Volume Pace | about 21 hours ago |
3x Volume Pace | about 21 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
SeaStar Medical Holding Corporation, a medical device company, develops cytopheresis systems for addressing inflammation-based diseases and conditions. The company focuses on acute renal failure, end-stage renal disease, and acute inflammation induced by cardiopulmonary bypass surgery. It develops products based on the configurations of commercially available hollow fiber dialysis filters that are used in a proprietary manner to sequester and deactivate leukocytes in the patient's blood system. The company was founded in 1994 and is based in Denver, Colorado.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Inflammation Kidney Disease Dialysis End Stage Renal Disease Kidney Nephrology Organ Failure Acute Kidney Injury Kidney Failure Cardiopulmonary Bypass Surgery
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Inflammation Kidney Disease Dialysis End Stage Renal Disease Kidney Nephrology Organ Failure Acute Kidney Injury Kidney Failure Cardiopulmonary Bypass Surgery
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 42.9225 |
52 Week Low | 2.9 |
Average Volume | 66,379 |
200-Day Moving Average | 11.16 |
50-Day Moving Average | 4.46 |
20-Day Moving Average | 3.80 |
10-Day Moving Average | 3.55 |
Average True Range | 0.30 |
RSI (14) | 23.08 |
ADX | 42.95 |
+DI | 6.74 |
-DI | 34.39 |
Chandelier Exit (Long, 3 ATRs) | 3.47 |
Chandelier Exit (Short, 3 ATRs) | 3.81 |
Upper Bollinger Bands | 4.51 |
Lower Bollinger Band | 3.09 |
Percent B (%b) | -0.04 |
BandWidth | 37.46 |
MACD Line | -0.39 |
MACD Signal Line | -0.34 |
MACD Histogram | -0.048 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.46 | ||||
Resistance 3 (R3) | 3.47 | 3.33 | 3.39 | ||
Resistance 2 (R2) | 3.33 | 3.22 | 3.33 | 3.37 | |
Resistance 1 (R1) | 3.18 | 3.15 | 3.11 | 3.17 | 3.34 |
Pivot Point | 3.04 | 3.04 | 3.00 | 3.04 | 3.04 |
Support 1 (S1) | 2.89 | 2.93 | 2.82 | 2.89 | 2.72 |
Support 2 (S2) | 2.75 | 2.86 | 2.75 | 2.69 | |
Support 3 (S3) | 2.60 | 2.75 | 2.67 | ||
Support 4 (S4) | 2.60 |